Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura Lukat"'
Autor:
Tobias Raphael Overbeck, Annika Reiffert, Katja Schmitz, Achim Rittmeyer, Wolfgang Körber, Sara Hugo, Juliane Schnalke, Laura Lukat, Tabea Hugo, Marc Hinterthaner, Kirsten Reuter-Jessen, Hans-Ulrich Schildhaus
Publikováno v:
Cancers, Vol 15, Iss 11, p 2966 (2023)
(1) Background: The main objectives of our study are (i) to determine the prevalence of NTRK (neurotrophic tyrosine kinase) fusions in a routine diagnostic setting in NSCLC (non-small cell lung cancer) and (ii) to investigate the feasibility of scree
Externí odkaz:
https://doaj.org/article/49345250d629498fa0182adab8e33929
Autor:
Omar Elakad, Anna‐Maria Lois, Katja Schmitz, Sha Yao, Sara Hugo, Laura Lukat, Marc Hinterthaner, Bernhard C. Danner, Alexander vonHammerstein‐Equord, Kirsten Reuter‐Jessen, Hans‐Ulrich Schildhaus, Philipp Ströbel, Hanibal Bohnenberger
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3574-3583 (2020)
Abstract Background Targeting fibroblast growth factor receptor 1 (FGFR1) is a potential treatment for squamous cell lung cancer (SQCLC). So far, treatment decision in clinical studies is based on gene amplification. However, only a minority of patie
Externí odkaz:
https://doaj.org/article/b11316f0c4c94414ad45bc3cdf35f622
Autor:
Kirsten Reuter-Jessen, Tessa Rosenthal, Laura Lukat, Annalen Bleckmann, Sara Hugo, Katja Schmitz, Achim Rittmeyer, Juliane Schnalke, Hans-Ulrich Schildhaus, Marc Hinterthaner, Wolfgang Körber, Dana Alina Cron, Joachim Moecks, Tabea Hugo, Tobias Overbeck
Publikováno v:
Translational Lung Cancer Research. 9:603-616
Ca Schildhaus Background: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definit
Autor:
Reinhard Inniger, Felix Bremmer, Laura Lukat, Alexander Fichtner, Philipp Ströbel, Ralph Triefenbach, Peter Mayer, H. U. Schildhaus
Publikováno v:
Virchows Archiv. 474:253-257
In addition to germ cell tumors and tumors of the sex cord stroma, the WHO classification of testis and paratesticular tumors also contains malignant soft tissue tumors. Among them, liposarcomas of the spermatic cord are the most common entities. Oth
Autor:
Tobias Raphael, Overbeck, Dana Alina, Cron, Katja, Schmitz, Achim, Rittmeyer, Wolfgang, Körber, Sara, Hugo, Juliane, Schnalke, Laura, Lukat, Tabea, Hugo, Marc, Hinterthaner, Kirsten, Reuter-Jessen, Tessa, Rosenthal, Joachim, Moecks, Annalen, Bleckmann, Hans-Ulrich, Schildhaus
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definition of MET pos
Autor:
Dirk Zielinski, Lena-Christin Conradi, Michael Ghadimi, Kia Homayounfar, Tim Beißbarth, Philipp Ströbel, Kirsten Reuter-Jessen, Annalen Bleckmann, Sara Hugo, Laura Lukat, Christina Koppel, Hans-Ulrich Schildhaus, Julia Elisabeth Fromme, Marius Grzelinski, Tabea Hugo, Katja Schmitz, Josef Rüschoff, Astrid Wachter
Publikováno v:
Oncotarget
// Julia Elisabeth Fromme 1, * , Katja Schmitz 1, * , Astrid Wachter 2 , Marius Grzelinski 3 , Dirk Zielinski 3 , Christina Koppel 3 , Lena-Christin Conradi 4 , Kia Homayounfar 4 , Tabea Hugo 1 , Sara Hugo 1 , Laura Lukat 1 , Josef Ruschoff 3 , Phili